Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-30
DOI
10.3389/fphar.2020.01089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
- (2020) Zongliang Zhang et al. Molecular Therapy-Oncolytics
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
- (2019) Hongwei Du et al. CANCER CELL
- B7-H3 immune checkpoint protein in human cancer
- (2019) Karine Flem-Karlsen et al. CURRENT MEDICINAL CHEMISTRY
- B7-H3 as a novel CAR-T therapeutic target for glioblastoma
- (2019) Xin Tang et al. Molecular Therapy-Oncolytics
- B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
- (2019) Dean Nehama et al. EBioMedicine
- B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models
- (2019) Baozhu Huang et al. OncoImmunology
- Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB
- (2018) Shiqi Li et al. BRITISH JOURNAL OF HAEMATOLOGY
- N-terminal α-amino group modification of antibodies using a site-selective click chemistry method
- (2018) De-zhi Li et al. mAbs
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- NK Cell-Based Immunotherapy in Cancer Metastasis
- (2018) Seila Lorenzo-Herrero et al. Cancers
- Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
- (2017) Maria Carmen Ochoa et al. IMMUNOLOGY AND CELL BIOLOGY
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
- (2016) E. Picarda et al. CLINICAL CANCER RESEARCH
- Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies
- (2016) Charli Dominguez et al. Cell Death & Disease
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3
- (2015) Mahiuddin Ahmed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
- (2015) Matthew G Oser et al. LANCET ONCOLOGY
- Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
- (2014) J Kraan et al. BRITISH JOURNAL OF CANCER
- Metastatic sites and survival in lung cancer
- (2014) M. Riihimäki et al. LUNG CANCER
- Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage
- (2013) A. Cohnen et al. BLOOD
- Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis
- (2013) Sabine Mellor-Heineke et al. Frontiers in Immunology
- Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
- (2013) Ursula J. E. Seidel et al. Frontiers in Immunology
- Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
- (2013) Laurent Boissel et al. OncoImmunology
- Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
- (2011) Andreas Brunner et al. GYNECOLOGIC ONCOLOGY
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
- (2009) Kim Kramer et al. JOURNAL OF NEURO-ONCOLOGY
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- The contrasting role of B7-H3
- (2008) K. A. Hofmeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now